Address
Kreos Capital
25-28 Old Burlington Street
London
W1S 3AN
United Kingdom
Phone
Website
Recent investment activity
KANDO id: 3537
Company type
Provider of flexible debt solutions to equity-backed, pan-European and Israeli high-growth companies in the technology and healthcare sectors.Funding rounds
Actual initial investment stage
Debt (2)
Investment activity status
Active investor
Selected investments
Displaying 51 - 71 of 71| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
|
Sequans Communications SA | LTE-based wireless solutions. | N/A | |||
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Siano Mobile Silicon Inc | N/A | ||||
|
Signal Media Ltd (Signal AI) | Series B | ||||
|
|
Signal Media Ltd (Signal AI) | Debt led the round | ||||
|
Silecs Oy | Advanced semiconductor materials. | N/A | |||
|
|
Silex Microsystems AB | N/A | ||||
|
|
SpineVision SA | N/A | ||||
|
The Currency Cloud Ltd (Currencycloud) | Payments automation platform designed to remit cross boarder payments through API. | Debt Initial investment led the round | |||
|
|
Transmode Systems AB | A leading provider of optical networking solutions for the transport of data, voice and video traffic, based on CWDM and DWDM technology. | N/A | |||
|
|
Tribold Ltd | N/A | ||||
|
|
Upfront Chromatography AS | N/A | ||||
|
|
Valens Semiconductor Ltd | N/A | ||||
|
|
Velocix Ltd | N/A | ||||
|
|
Wilocity Inc | N/A | ||||
|
Wonga.com Ltd | UK-based provider of short-term cash advances. | N/A | |||
|
|
Xelerated AB | N/A | ||||
|
|
Xeround Inc | N/A | ||||
|
|
XJet Ltd | N/A | ||||
|
|
Xtellus Inc | Dynamic optical components and modules company for multi-wavelength, reconfigurable optical networking systems. | N/A | |||
|
|
Zed Worldwide SA | N/A |
| Company | Profile | Country | Funding | ||
|---|---|---|---|---|---|
|
Calliditas Therapeutics AB | Biopharma company focused on identifying, developing, and commercialising novel treatments in orphan indications with significant unmet medical needs. | Debt Initial investment led the round EUR 68,000,000 Exited Repayment of preference shares/ loans or mezzanine |